Preparing for Patient-Centric Drug Development Regulations

10 September 2018 16:35 - 17:20

  • What do the recent FDA Guidelines on Patient-Focused Drug Development (PFDD) mean to us?
  • Why do we need more patient focussed thinking and design of drug products, medical devices and combination products?
  • How will become more patient focussed shake up the industry and make us more competitive

Dr. Jamie Unwin, Commercial Insights Officer, Nanoform

Hannah Mann, Founding Partner, Day One

Mike Rea, CEO, IDEA Pharma

Twinkle Christian, Process Development Scientist, Drug Product Technologies Group , Amgen

Yasmine Gomaa, Senior Research Scientist and Associate Director, Laboratory of Drug Delivery, Georgia Institute of Technology